Patricia Dorling
Senior Director - Health Economics, Outcomes Research & Gene Therapy Portfolio Lead Insmed
Patricia Dorling, PharmD, MS, PhD, is a global leader in Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE), with 15+ years across oncology, rare diseases, gene therapy, and internal medicine. As Senior Director of HEOR Gene Therapy Portfolio Lead at Insmed, she leads evidence strategy for gene therapies. Previously Vice President and Head of Global HEOR & Medical RWE at Chiesi, she scaled functions for rare disease portfolios. An expert in evidence generation, HTA, and RWE innovation, she drives launches, speaks at conferences, and champions diversity through D&I networks.
Seminars
This interactive workshop moves beyond theoretical AI discussions to focus on practical, regulated, decision‑grade adoption of AI (including agentic AI) in real‑world evidence environments. The session will emphasize governance tradeoffs, enterprise implementation realities, and lessons learned from what has genuinely scaled, and what has failed.
This workshop will gather experts to discuss:
- What Has Fundamentally Changed with AI, Agentic AI, and Digital Innovation in RWE
- Trust, Transparency, and Trustworthiness Across the Data Lifecycle
- From Generic AI to Pharma‑Specific, Decision‑Grade Use Cases
- Governance, Validation, and Risk Mitigation in Regulated Environments
- Enterprise Implementation Lessons on Where AI Has Delivered & Where It Has Failed
- Building organizational readiness for AI‑enabled RWE
